Immune Drug Helps Relapsing Kidney Disease
(Ivanhoe Newswire) –A recent study shows that in patients with a frequently-relapsing form of kidney disease, relapses decreased approximately five-fold for at least one year after patients took a single dose of rituximab.
For many patients with a kidney disorder called idiopathic nephrotic syndrome (INS), the disease is thought to arise from an abnormal immune response. Researchers have shown that the drug can help children with INS that responds to standard treatments consisting of immunosuppressants and steroids. Therefore, rituximab may allow patients to discontinue the potentially toxic medications, which can affect children’s growth and can increase patients’ risks for heart problems, cancer, infections, and other conditions.
For more information, go to: http://jasn.asnjournals.org/content/early/2014/01/29/ASN.2013030251.full?sid=f5e162b9-e9e9-4795-b2d8-77d60e5d7fba
SOURCE: Journal of the American Society of Nephrology, January 2014
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.